APA (7th ed.) Citation

A, A., DHCA, B., D, K., AR, A., JF, C., R, S., . . . Z, M. (2024). Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply. Alimentary pharmacology & therapeutics, 59(12), 1646. https://doi.org/10.1111/apt.18031

Chicago Style (17th ed.) Citation

A, Aliu, et al. "Letter: Intestinal Permeability Accounting for Ongoing Gastrointestinal Symptoms Following Endoscopic Remission in IBD-Authors' Reply." Alimentary Pharmacology & Therapeutics 59, no. 12 (2024): 1646. https://doi.org/10.1111/apt.18031.

MLA (9th ed.) Citation

A, Aliu, et al. "Letter: Intestinal Permeability Accounting for Ongoing Gastrointestinal Symptoms Following Endoscopic Remission in IBD-Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 59, no. 12, 2024, p. 1646, https://doi.org/10.1111/apt.18031.